Myocardial Inflammation
12
2
2
8
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
16.7%
2 terminated out of 12 trials
80.0%
-6.5% vs benchmark
17%
2 trials in Phase 3/4
38%
3 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
TIRANA-ACS: A Prospective Registry Study for the Targeted Investigation of Residual Inflammation After Non-ST/ ST Elevation Acute Coronary Syndrome
CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance
Effects of SGLT-2 Inhibition on Myocardial Fibrosis and Inflammation as Assessed by Cardiac MRI in Patients With DM2
COUREUR Study Myocardial Inflammation in Cyclist Part 1
COUREUR Study Myocardial Inflammation in Cyclist Part 2
Myocardial Inflammation in Rheumatoid Arthritis: A Descriptive Study
Lymphatic Organs and Myocardium After Myocardial Infarction
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation
Mer-TK in Human Cardiac Cells
Impact of 100mL Lipid Emulsion for Intravenous for Suppression of Myocardial Glucose Metabolism in 18F-FDG PET/CT
Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma